Načítá se...
A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCI
BACKGROUND: A thorough understanding of the patient's genotype and their functional response to a medication is necessary for improving event free survival. Several outcome studies support this view particularly if the patient is to be started on clopidogrel due to the prevalence of clopidogrel...
Uloženo v:
| Vydáno v: | Indian Heart J |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4475902/ https://ncbi.nlm.nih.gov/pubmed/26071289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2015.03.017 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|